AI Flags a Hypertensive Crisis Before Blood Pressure Turns Emergently High
Continuous data from a portable cuff-based monitor and a wrist-worn tracker may give clinicians a short window to intervene before hypertensive crisis becomes an emergency. In a 12-month study of adults with stage 2 hypertension, an AI model identified patterns associated with crisis risk up to 72 hours in advance, with the strongest signals coming from abnormal overnight blood pressure behavior and an exaggerated surge after waking.
The clinical appeal is straightforward. Office readings capture a single moment, while blood pressure instability often unfolds over sleep, waking, and daily activity. In this study, the algorithm examined repeated blood pressure values from a cuff-based monitor alongside heart rate and heart rate variability from a wearable device, then issued an alert when risk appeared elevated. Physicians receiving the alert could contact the patient, review symptoms, and adjust medication when needed.
A hypertensive crisis is not just a high number on a cuff. It is defined here as blood pressure above 180/120 mm Hg with acute end-organ damage, the kind of event that can lead to stroke, myocardial infarction, kidney injury, aortic dissection, or pulmonary edema. When the blood pressure trajectory is unstable enough to foreshadow that kind of collapse, the biology matters as much as the reading itself.
Sleep Patterns and Morning Surges Carried the Strongest Signal
The dataset included 4,190 adults ages 40 to 85, with an average age of 62.4 years. Women made up 46% of the cohort and men 54%. All participants had stage 2 hypertension, and all were cared for at one hospital in Sindh, Pakistan between January 2025 and January 2026.
Over the study period, 312 participants experienced 418 hypertensive crises, representing about 7% of the cohort. The AI model distinguished higher-risk from lower-risk patients as far as 72 hours before the crisis occurred. Among those with a positive alert, about 32% went on to have a crisis, while 97.4% of those without an alert stayed crisis-free.
Two physiological patterns stood out. When blood pressure failed to fall during sleep, the odds of an upcoming crisis were nearly five times higher. When blood pressure rose by more than 35 mm Hg after waking compared with the nighttime level, the odds were nearly four times higher. Those are not trivial fluctuations. They suggest loss of the normal nocturnal “dipping” pattern and an exaggerated sympathetic rebound at wake-up, both of which can strain vulnerable vessels and organs during a period when patients may feel well enough to ignore the warning.
One sentence captures the bedside reality: the most dangerous rise often began before symptoms did.
The model reviewed 47 characteristics drawn from the blood pressure monitor and wearable tracker, including sleep-related decline, waking surge, blood pressure trends over time, and changes in heart rate. By combining these signals rather than relying on a single reading, the system appears to have captured a more complete picture of short-term hemodynamic stress.
Early Alerts Were Linked to Fewer Crises and Fewer Emergency Visits
The most clinically provocative result came when alerts led to action within 24 hours. Among patients whose physicians received an AI alert and adjusted medications promptly, hypertensive crises were about 61% lower and emergency department visits were about 45% lower compared with people who did not receive timely alert-triggered intervention.
Those findings point to a mechanism that is easy to understand at the bedside. If a patient’s blood pressure is drifting upward overnight and then spiking in the morning, medication adjustment, symptom review, and confirmation of adherence may interrupt the path toward vascular injury before the episode becomes a hospital event. In practical terms, the system may be identifying a window when treatment intensification still has time to work.
Waleed Razzaq Chaudhry, M.D., the lead study author and an internal medicine resident at the University of Maryland Capital Region Medical Center in Largo, Maryland, framed the issue around a familiar limitation in hypertension care: a single measurement cannot show the full day-night pattern. Maria Delgado-Lelievre, M.D., a hypertension specialist at the University of Miami Leonard M. Miller School of Medicine, emphasized the same point from a care-delivery perspective, saying that tools with more insight between office visits may help support more personalized care and earlier discussions about treatment, lifestyle changes, and medication adherence.
The data fit that view. A brief office visit can miss nocturnal non-dipping, morning surges, and unstable heart rate patterns, all of which may reflect autonomic stress, volume shifts, or suboptimal treatment coverage across a 24-hour cycle. Continuous monitoring does not replace clinical judgment, but it can expose patterns that a routine checkup cannot see.
A Single-Hospital Cohort Limits General Use, and the Device Question Remains Open
The study is preliminary, and several boundaries matter before this approach can be used broadly. Every participant lived in Pakistan and received care at one hospital, so the findings need testing in more diverse populations and in different healthcare settings. The release also notes that more research is needed to guide exactly how clinicians should respond to a high-risk alert, including confirming blood pressure, reviewing symptoms and adherence, contacting the patient, adjusting medication, and deciding when urgent or emergency evaluation is necessary.
Device performance is another unresolved issue. A 2025 American Heart Association scientific statement on cuffless technologies called for more research and standardized testing before those devices are used to guide care. The Association still recommends an automatic, cuff-style, upper arm monitor, and it does not recommend wrist or finger monitors because their readings are less reliable. In this study, the wearable component provided cardiovascular signals, while the blood pressure monitor supplied repeated cuff-based values; the distinction is important when the endpoint is a hypertensive emergency.
The abstract was presented for Scientific Sessions 2026 and remains preliminary until a full manuscript is published in a peer-reviewed journal. That limitation is not a footnote. It defines how far the results can travel today. For now, the study suggests that combining continuous blood pressure monitoring with AI may detect a dangerous trajectory days before the crisis threshold is crossed, but the next step is proving that this kind of alert can be deployed safely, consistently, and in a way that improves outcomes across settings far beyond a single hospital cohort.